Invention Grant
- Patent Title: Efficient systemic treatment of dystrophic muscle pathologies
-
Application No.: US15321416Application Date: 2015-04-24
-
Publication No.: US10166272B2Publication Date: 2019-01-01
- Inventor: George Dickson , Thomas Voit , Philippe Moullier , Caroline Le Guiner
- Applicant: GENETHON , ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE
- Applicant Address: FR Evry GB Egham Surrey
- Assignee: GENETHON,ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE
- Current Assignee: GENETHON,ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE
- Current Assignee Address: FR Evry GB Egham Surrey
- Agency: Seed IP Law Group LLP
- Priority: EP14174848 20140627
- International Application: PCT/EP2015/058964 WO 20150424
- International Announcement: WO2015/197232 WO 20151230
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K48/00 ; C12N7/00 ; C12N15/86
Abstract:
A composition comprising a gene therapy product for use in the treatment of a dystrophic disease in a subject, advantageously in humans, wherein: —the gene therapy product comprises a nucleic acid sequence encoding a functional microdystrophin; —the composition is systemically administered.
Public/Granted literature
- US20170157213A1 EFFICIENT SYSTEMIC TREATMENT OF DYSTROPHIC MUSCLE PATHOLOGIES Public/Granted day:2017-06-08
Information query
IPC分类:
